Nobuo Nagai Selected Research

Nobuo Nagai Research Topics

Disease

9	Stroke (Strokes) 12/2015 - 09/2003
5	Ischemic Stroke 01/2016 - 02/2008
4	Brain Ischemia (Cerebral Ischemia) 01/2016 - 04/2004
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2015 - 06/2002
4	Ischemia 01/2011 - 09/2003
4	Thrombosis (Thrombus) 01/2008 - 12/2004
3	Infarction (Infarctions) 03/2008 - 09/2003
3	Obesity 01/2008 - 10/2007
2	Hemorrhage 01/2011 - 10/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2010 - 03/2008
2	Retinal Neovascularization 04/2009 - 03/2008
1	Reperfusion Injury 01/2016
1	Brain Injuries (Brain Injury) 12/2015
1	Neoplasms (Cancer) 01/2015
1	Cerebral Infarction 01/2012
1	Animal Disease Models 01/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2011
1	Pathologic Neovascularization 04/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2008
1	Body Weight (Weight, Body) 01/2008
1	Thrombotic Stroke 10/2004
1	Cerebral Hemorrhage 04/2004
1	Hypoxia (Hypoxemia) 09/2003

Drug/Important Bio-Agent (IBA)

8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2016 - 06/2002
4	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 04/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 09/2003
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 04/2010
2	Pharmaceutical PreparationsIBA 01/2012 - 01/2011
2	Vascular Endothelial Growth Factor BIBA 04/2009 - 03/2008
2	Plasminogen Activator Inhibitor 1IBA 03/2008 - 01/2008
2	microplasminIBA 08/2007 - 10/2004
2	Fibrinolysin FDA Link 06/2005 - 10/2004
1	LDL Receptors (LDL Receptor)IBA 12/2015
1	Dynactin ComplexIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	Oncogene Proteins (Oncogene Protein)IBA 01/2015
1	Coloring Agents (Dyes)IBA 01/2012
1	Evans Blue (Blue, Evans)FDA Link 01/2012
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2011
1	NeurotoxinsIBA 04/2010
1	platelet-derived growth factor C (PDGF-C)IBA 04/2010
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 10/2009
1	Endothelin B ReceptorIBA 03/2008
1	Glutamic Acid (Glutamate)FDA Link 03/2008
1	Urokinase Plasminogen Activator ReceptorsIBA 02/2008
1	rofecoxib (Vioxx)FDA Link 01/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008
1	ferric chlorideIBA 01/2008
1	Factor V (Coagulation Factor V)IBA 01/2008
1	factor V LeidenIBA 10/2007
1	Therapeutic UsesIBA 08/2007
1	Gadolinium DTPA (Magnevist)FDA Link 12/2004
1	Heparin (Liquaemin)FDA LinkGeneric 04/2004
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2003
1	SurvivinIBA 09/2003

Therapy/Procedure

3	Therapeutics 01/2015 - 04/2004
2	Thrombolytic Therapy 12/2015 - 04/2004
1	Treatment Delay 01/2011
1	Axotomy 04/2010